Lutz Heinemann, Germany

Profil Institut für Stoffwechselforschung Profil Institut für Stoffwechselforschung
Prof. Dr. Lutz Heinemann, PhD • CEO of Profil Institut für Stoffwechselforschung GmbH 1999 – 2009 • Partner and Scientific Consultant Profil Institut für Stoffwechselforschung and Profil Institut for Clinical Research Ltd. since 2009 • Coordinator AP@home, an EU-funded Research Project 2010 - 2015 • Managing Editor of the Journal of Diabetes Science and Technology since August 2011

Presenter of 3 Presentations

PARALLEL SESSION

Introduction

PLENARY SESSION

New Insulins, Biosimilars and Insulin Therapy

Date
Fri, 04.06.2021
Lecture Time
14:31 - 14:37
ORAL PRESENTATION SESSION

TIME TREND OF DIABETOLOGISTS' ATTITUDES TOWARDS DIGITALIZATION AND NEW TECHNOLOGISTS AND THEIR ADVANTAGES AND DISADVANTAGES

Abstract

Background and Aims

Despite many new innovations, little is known to date about diabetologists' attitudes and expectations regarding digitization and new technologies in diabetology and how they are changing over time.
For the "Digitization and Technology Report Diabetes 2021", diabetologists nationwide in Germany were asked from August to October 2020 about their attitudes toward diabetes technologies and digitization in diabetology, among other things, and compared with a similar survey in 2018/2019.

Methods

337 diabetologists (2018: 422; 2019: 324) participated in the survey (43% female, average age 53.2 years). On average, 324 people with diabetes using Flash-Glucose-Monitoring, 100 using real-time continuous glucose monitoring (CGM), and 94 using insulin pump therapy (CSII) were treated per diabetes institution in 2020.

Results

In 2020, 81.9% (2019: 75.8%; 2018: 63.7%) of the physicians surveyed had a positive or very positive attitude toward digitization, with only 3.6% having a negative attitude toward it (2019: 4.3%, 2018: 8.0%). The benefits of digitization for diabetology rated as greatest were "better metabolic control of patients" (75.9%), "better quality of own work" (74.1%) "more personalized treatment of patients in terms of personalized diabetes therapy" (71.9%), and "specialization of own institution" (65.9%). The "unclear and insufficient reimbursement of digital services" (89.6%) is stated as the greatest disadvantage.

Conclusions

The potential of digitization is considered to be very high by diabetologists. The comparison of the previous 3 surveys (2019,2020, 2021) indicates that the positive attitude towards digitization has increased even more in recent years and that a very positive basic mood now prevails among most respondents.

Hide

Moderator of 1 Session

PARALLEL SESSION
Date
Sat, 05.06.2021
Session Type
PARALLEL SESSION
Session Time
15:45 - 17:25
Room
Hall B